Drug Insights

Unveiling Azithromycin: How to Search for it on Synapse

4 February 2024
2 min read

Azithromycin, a small molecule drug, works by targeting the 50S subunit of the bacterial ribosome and disrupting protein synthesis, ultimately leading to bacterial death. This drug falls under the class of macrolide antibiotics and is commonly used to treat a diverse range of bacterial infections, such as respiratory tract infections, skin and soft tissue infections, and sexually transmitted infections. It is also used as a prophylactic treatment for certain opportunistic infections in HIV patients. Azithromycin gained FDA approval in 1991, representing a significant breakthrough in the field of antibiotic development. With its broad-spectrum activity against a wide range of bacterial species, Azithromycin is a valuable tool for healthcare providers in managing bacterial infections. However, the overuse or misuse of antibiotics such as Azithromycin can lead to the emergence of antibiotic-resistant bacteria. Therefore, healthcare providers must exercise caution and prudence when prescribing Azithromycin to prevent the development of antibiotic resistance. Overall, Azithromycin is a potent antibiotic that plays a crucial role in the treatment of bacterial infections. Click on the image below to begin the exploration journey of Azithromycin through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Asieris Presents Early Results of APL-1202 and Tislelizumab Study for Advanced Bladder Tumors at ASCO-GU 2024
Latest Hotspot
3 min read
Asieris Presents Early Results of APL-1202 and Tislelizumab Study for Advanced Bladder Tumors at ASCO-GU 2024
4 February 2024
Asieris Debuts Preliminary Results from Study on APL-1202 Pill Paired with Immune Checkpoint Blocker Tislelizumab for Pre-Surgical Care in Advanced Urinary Bladder Tumors at ASCO-GU 2024 Event.
Read →
Expert Tips for Searching Amitriptyline on Synapse
Drug Insights
2 min read
Expert Tips for Searching Amitriptyline on Synapse
4 February 2024
Amitriptyline Hydrochloride, a small molecule drug, is a reuptake inhibitor targets the monoamine transporters.
Read →
Celltrion USA Finalizes Application for Biosimilar Approval, Targets CT-P47 (ACTEMRA® Counterpart)
Latest Hotspot
3 min read
Celltrion USA Finalizes Application for Biosimilar Approval, Targets CT-P47 (ACTEMRA® Counterpart)
4 February 2024
Celltrion USA has finalized its application for a biosimilar approval, targeting CT-P47, a counterpart to the drug ACTEMRA® (tocilizumab).
Read →
Navigating Health Information: How to Use Synapse to Search for Diclofenac
Drug Insights
2 min read
Navigating Health Information: How to Use Synapse to Search for Diclofenac
4 February 2024
Diclofenac Sodium, a minuscule molecule drug, wields its prowess by targeting the COX enzyme as an inhibitor.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.